ArticleMedComm2026

Bispecific NK-Cell Engager Targeting TP53 Mutation Through Integration of a TCR-mimic Antibody.

Hanfei Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.